Stock Price
3.02
Daily Change
0.05 1.68%
Monthly
-3.21%
Yearly
106.85%
Q1 Forecast
2.88

Galectin Therapeutics reported $93.42M in Loan Capital for its fiscal quarter ending in June of 2024.





Loan Capital Change Date
AbbVie USD 62.97B 12M Sep/2025
Bristol-Myers Squibb USD 42.85B 1.62B Dec/2025
Galectin Therapeutics USD 93.42M 9.08M Jun/2024
Gilead Sciences USD 22.14B 5M Sep/2025
Immunic USD 0 0 Jun/2024
Incyte USD 30.2M 5.17M Dec/2025
Merck USD 39.97B 6B Sep/2025